Enlivex Therapeutics (NASDAQ:ENLV – Get Free Report) is scheduled to issue its quarterly earnings data on Wednesday, August 23rd. Enlivex Therapeutics (NASDAQ:ENLV – Get Free Report) last released its earnings results on Friday, June 16th. The company reported ($0.39) earnings per share for the quarter, beating the consensus estimate of ($0.40) by $0.01. On average, […]
Short Interest in Enlivex Therapeutics Ltd (NASDAQ:ENLV) Increases By 8 6% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Enlivex Therapeutics Ltd. (NASDAQ:ENLV – Get Free Report) was the recipient of a large increase in short interest in July. As of July 31st, there was short interest totalling 113,600 shares, an increase of 8.6% from the July 15th total of 104,600 shares. Based on an average trading volume of 23,300 shares, the days-to-cover ratio […]
HC Wainwright reaffirmed their buy rating on shares of Enlivex Therapeutics (NASDAQ:ENLV – Free Report) in a research report released on Tuesday morning, Benzinga reports. They currently have a $15.00 target price on the stock. HC Wainwright also issued estimates for Enlivex Therapeutics’ Q2 2023 earnings at ($0.43) EPS, Q3 2023 earnings at ($0.39) EPS, […]
HC Wainwright restated their buy rating on shares of Enlivex Therapeutics (NASDAQ:ENLV – Free Report) in a research report released on Tuesday, Benzinga reports. HC Wainwright currently has a $15.00 price target on the stock. HC Wainwright also issued estimates for Enlivex Therapeutics’ Q2 2023 earnings at ($0.43) EPS, Q3 2023 earnings at ($0.39) EPS, […]